Anacor Pharma (ANAC) Reports Positive P-3 Data on Tavaborole for Onychomycosis
Go back to Anacor Pharma (ANAC) Reports Positive P-3 Data on Tavaborole for OnychomycosisANACOR PHARM (NYSE: ANAC) | Delayed: 10.19 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $10.19 | 52 Week High | $156.93 | |||
Open | $10.19 | 52 Week Low | $52.00 | |||
Day High | $10.19 | P/E | N/A | |||
Day Low | $10.19 | EPS | $-1.54 | |||
Volume | 50 |